Keep Me Logged In
CNBC's Meg Tirrell speaks with John Maraganore, Alnylam CEO, about pricing for his company's new drug and his thoughts on Amazon's potential break into the biopharma industry.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by